In its assignment as liquidity guarantor, Lago Kapital will ensure the opportunity to trade in the company's shares by continuously placing trading items on each buy and sell page in the order book. This is in accordance with Nasdaq First North Growth Market regulations regarding liquidity guarantee and means that the liquidity guarantor quotas the purchase and sale volume corresponding to at least
For this purpose,
For more information on
John Öhd, VD,
Telefon: +46 (0) 70 766 80 97
E-post: john.ohd@modustx.com
Certified Adviser
Telefon: +46 11 32 30 732
E-post: ca@skmg.se
About
Sevuparin is a clinical stage, innovative proprietary polysaccharide drug with a multimodal mechanism of action, including anti-inflammatory, anti-adhesive and anti-aggregate effects. Sevuparin is a heparinoid with markedly attenuated anti-coagulation features that allows severalfold higher doses to be given, compared to regular heparinoids, without the associated risk for bleeding side-effects. Two routes of administration of sevuparin are currently being tested - an IV formulation for in-patient administration and a subcutaneous formulation that allows ambulatory and home care administration.
https://news.cision.com/modus-therapeutics/r/modus-therapeutics-engages-lago-kapital-as-a-liquidity-guarantor,c3437764
https://mb.cision.com/Main/20380/3437764/1484378.pdf
(c) 2021 Cision. All rights reserved., source